S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 181 to 240 of 245

Issue Date	Title / Author(s) / Citation	File
2016-08	Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study Lee, Dong Ho; Kim, Se Hyung; Im, Seock-Ah; Oh, Do-Youn; Kim, Tae-Yong; Han, Joon Koo European Radiology, Vol.26 No.8, pp.2771-2778	DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2016-10	Phase II trial of dacomitinib in patients with HER2-positive gastric cancer Oh, Do-Youn; Lee, Kewn-Wook; Cho, Jae Yong; Kang, Won Ki; Im, Seock-Ah; Kim, Jin Won; Bang, Yung-Jue Gastric Cancer, Vol.19 No.4, pp.1095-1103	DOI
2016-10	Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy Koh, Hyeon Kang; Chie, Eui Kyu; Kim, Kyubo; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Ha, Sung W. Anticancer Research, Vol.36 No.10, pp.5455-5461	DOI
2016-11	Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Oncotarget, Vol.7 No.47, pp.76604-76612	DOI
2016-11	TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials Lee, Dae-Won; Jang, Myoung-Jin; Lee, Kyung-Hun; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You British Journal of Cancer, Vol.115 No.10, pp.1201-1205	DOI
2017-01	Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells Kim, Hee-Jun; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Lee, Kyung Hun; Lau, Alan; Lee, Miso; Kim, Seongyeong; Yang, Yaewon; Kim, Jungeun; Kim, Tae Yong; Oh, Do-Youn; Brown, Jeffrey; O'Connor, Mark J.; Bang, Yung-Jue International Journal of Cancer, Vol.140 No.1, pp.109-119	DOI
2017-01	Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.1, pp.164-174	DOI
2017-01	Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.2, pp.2329-2341	DOI
2017-03	Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Lee, Joongyub; Bang, Ju-Hee; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.2, pp.254-262	DOI
2017-03	Optimal Timing of Influenza Vaccination During 3-Week Cytotoxic Chemotherapy Cycles Keam, Bhumsuk; Kim, Min-Kyung; Choi, Yunhee; Choi, Su-Jin; Choe, Pyoeng Gyun; Lee, Kyung-Hun; Kim, Tae Min; Kim, Tae-Yong; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Nam-Joong; Heo, Dae Seog; Park, Wan Beom; Oh, Myoung-don Cancer, Vol.123 No.5, pp.841-848	DOI
2017-04	Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Kwon, Jeanny; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.2, pp.473-483	DOI
2017-04	Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea Beom, Seung Hoon; Oh, Jisu; Kim, Tae-Yong; Lee, Kyung-Hun; Yang, Yaewon; Suh, Koung Jin; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.2, pp.454-463	DOI
2017-04	Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy Lim, Yu Jin; Koh, Jaemoon; Kim, Kyubo; Chie, Eui Kyu; Kim, Sehui; Lee, Kyoung Bun; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue Targeted Oncology, Vol.12 No.2, pp.211-218	DOI
2017-04	Phosphorylated Akt expression as a favorable prognostic factor for patients undergoing curative resection and adjuvant chemoradiotherapy for proximal extrahepatic bile duct cancer Kim, Byoung Hyuck; Kim, Kyubo; Min, Hye Sook; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Jang, Ja-June; Ha, Sung W. American Journal of Clinical Oncology, Vol.40 No.2, pp.158-162	DOI
2017-04	AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Seongyeong; Lee, Miso; Kim, Debora Keunyoung; Yang, Yaewon; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Jin Won; Kim, Tae-Yong; Oh, Do-Youn; Brown, Jeff; Lau, Alan; O'Connor, Mark J.; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.16 No.4, pp.566-577	DOI
2017-05	Risk stratification and prognostic nomogram for postrecurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Kwon, Jeanny; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue HPB, Vol.19 No.5, pp.421-428	DOI
2017-06	Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Molecular Cancer Therapeutics, Vol.16 No.6, pp.1145-1154	DOI
2017-06	Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication Park, Seongyeol; Ha, Seunggyun; Kwon, Hyun Woo; Kim, Woo Hyoung; Kim, Tae-Yong; Oh, Do-Youn; Cheon, Gi Jeong; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.58 No.6, pp.899-904	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-08	Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer Jo, Jaemin; Kwon, Hyun Woo; Park, Seongyeol; Oh, Do-Youn; Cheon, Gi Jeong; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.58 No.8, pp.1255-1261	DOI
2017-09	Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution Kim, Byoung Hyuck; Chie, Eui Kyu; Kim, Kyubo; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue; Ha, Sung W. Oncotarget, Vol.8 No.44, pp.78076-78085	DOI
2017-10	Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79441-79452	DOI
2017-11	Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel Park, Jiyoung; Choi, Yonghwan; Namkung, Junghyun; Yi, Sung Gon; Kim, Hyunsoo; Yu, Jiyoung; Kim, Yongkang; Kwon, Min-Seok; Kwon, Wooil; Oh, Do-Youn; Kim, Sun-Whe; Jeong, Seung-Yong; Han, Wonshik; Lee, Kyu Eun; Heo, Jin Seok; Park, Joon Oh; Park, Joo Kyung; Kim, Song Cheol; Kang, Chang Moo; Lee, Woo Jin; Lee, Seungyeoun; Han, Sangjo; Park, Taesung; Jang, Jin-Young; Kim, Youngsoo Oncotarget, Vol.8 No.54, pp.93117-93130	DOI
2017-12	Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy Kim, Yi-Jun; Koh, Hyeon Kang; Chie, Eui Kyu; Oh, Do-Youn; Bang, Yung-Jue; Nam, Eun Mi; Kim, Kyubo International Journal of Clinical Oncology, Vol.22 No.6, pp.1069-1075	DOI
2018-02	Phase I pharmacokinetic study of nivolumab in Korean patients with advanced solid tumors Lee, Keun-Wook; Lee, Dae Ho; Kang, Jin Hyoung; Park, Joon Oh; Kim, Se Hyun; Hong, Yong Sang; Kim, Seung Tae; Oh, Do-Youn; Bang, Yung-Jue Oncologist, Vol.23 No.2, pp.155-e17	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2018-05	High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients Park, Younghee; Kim, Kyubo; Paik, Jin Ho; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn European Journal of Surgical Oncology, Vol.44 No.5, pp.638-643	DOI
2018-05	Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells Min, Ahrum; Kim, Jung Eun; Kim, Yu-Jin; Lim, Jee Min; Kim, Seongyeong; Kim, Jin Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Letters, Vol.430, pp.123-132	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2019-02	Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial Chung, Hyun Cheol; Arkenau, Hendrik-Tobias; Lee, Jeeyun; Rha, Sun Young; Oh, Do-Youn; Wyrwicz, Lucjan; Kang, Yoon-Koo; Lee, Keun-Wook; Infante, Jeffrey R; Lee, Sung Sook; Kemeny, Margaret; Keilholz, Ulrich; Melichar, Bohuslav; Mita, Alain; Plummer, Ruth; Smith, Denis; Gelb, Arnold B; Xiong, Huiling; Hong, Janet; Chand, Vikram; Safran, Howard Journal for ImmunoTherapy of Cancer. 2019 Feb 04;7(1):30	view file DOI
2019-04	Dynamics of soluble programmed death-ligand 1 (SPDL1) during chemotherapy and its prognostic implications in cancer patients: Biomarker development in immuno-oncology Ha, Hyerim; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji-Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Research and Treatment, Vol.51 No.2, pp.832-840	DOI
2019-04	Pan-PIM kinase inhibitor AZD1208 suppresses tumor growth and synergistically interacts with AKT inhibition in gastric cancer cells Lee, Miso; Lee, Kyung-Hun; Min, Ahrum; Kim, Jeongeun; Kim, Seongyeong; Jang, Hyemin; Lim, Jee Min; Kim, So Hyeon; Ha, Dong-Hyeon; Jeong, Won Jae; Suh, Koung Jin; Yang, Yae-Won; Kim, Tae Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.51 No.2, pp.451-463	DOI
2019-05	Prognostic effects of abnormal DNA damage response protein expression in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.175 No.1, pp.117-127	DOI
2019-07	Therapeutic targeting of the DNA damage response using an ATR inhibitor in biliary tract cancer Nam, Ah-Rong; Jin, Mei Hua; Park, Ji Eun; Bang, Ju-Hee; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.51 No.3, pp.1167-1179	DOI
2019-07	Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients Kim, Jung Youn; Lee, Dae-Won; Lee, Kyung-Hun; Min, Ahrum; Ryu, Han Suk; Lee, Han-Byoel; Moon, Hyeong-Gon; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah; Kim, Sukil Breast Cancer Research and Treatment, Vol.176 No.2, pp.453-460	DOI
2019-07	Jab1 silencing inhibits proliferation and sensitizes to cisplatin in biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.51 No.3, pp.886-900	DOI
2019-07	Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients Lee, Dae-Won; Ryu, Han Suk; Jin, Min-Sun; Lee, Kyung-Hun; Suh, Koung Jin; Youk, Jeonghwan; Kim, Jung Youn; Min, Ahrum; Lee, Han-Byoel; Moon, Hyeong-Gon; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah British Journal of Cancer, Vol.121 No.3, pp.230-236	DOI
2019-08	A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors Oh, Do-Youn; Lee, Keun-Wook; Han, Sae-Won; Kim, Jin Won; Shin, Jung-Won; Jo, Seong-Jin; Won, Jonghwa; Hahn, Seokyung; Lee, Howard; Kim, Woo Ho; Bang, Yung-Jue Oncologist, Vol.24 No.8, pp.1037-e636-+	DOI
2019-08	Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: Phase Ib study Kim, Jin Won; Lee, Kyung-Hun; Kim, Ji-Won; Suh, Koung Jin; Nam, Ah-Rong; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn British Journal of Cancer, Vol.121 No.4, pp.332-339	DOI
2019-09	GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer Park, Ji Eun; Jin, Mei Hua; Hur, Minkyu; Nam, Ah-Rong; Bang, Ju-Hee; Won, Jonghwa; Oh, Do-Youn; Bang, Yung-Jue Gastric Cancer, Vol.22 No.5, pp.932-940	DOI
2019-11	Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis Park, Changhee; Keam, Bhumsuk; Yoon, Soon Ho; Ock, Chan-Young; Choi, Sun Mi; Kim, Miso; Park, Young Sik; Kim, Tae Min; Oh, Do-Youn; Kim, Dong-Wan; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Esmo Open, Vol.4 No.6, p. e000575	DOI
2019-12	Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Scientific Reports, Vol.9 No.1, p. 11131	DOI
2020-01	Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Cancer Research and Treatment, Vol.52 No.1, pp.149-166	view file DOI
2020-01	Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study Yoo, Shin Hye; Kang, Seo Young; Cheon, Gi Jeong; Oh, Do-Youn; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.61 No.1, pp.33-39	DOI
2020-01	HER2-targeted therapies - a role beyond breast cancer Oh, Do-Youn; Bang, Yung-Jue Nature Reviews Clinical Oncology, Vol.17 No.1, pp.33-48	DOI
2020-01	The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Medicine, Vol.9 No.1, pp.43-51	DOI
2020-02	TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy Kim, Jin Won; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Yu Jin; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Keun Wook; Oh, Do-Youn; Kim, Jee-Hyun; Bang, Yung-Jue Cancers, Vol.12 No.2, p. 334	view file DOI
2020-02	Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study Bang, Yung-Jue; Li, Chung-Pin; Lee, Kyung-Hun; Chiu, Chang-Fang; Park, Joon Oh; Shan, Yan-Shen; Kim, Jun Suk; Chen, Jen-Shi; Shim, Hyun-Jeong; Rau, Kun-Ming; Choi, Hye Jin; Oh, Do-Youn; Belanger, Bruce; Chen, Li-Tzong Cancer Science, Vol.111 No.2, pp.513-527	view file DOI
2020-07	Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer Nam, Ah-Rong; Jin, Mie-Hua; Bang, Ju-Hee; Oh, Kyoung-Seok; Seo, Hye-Rim; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.52 No.3, pp.945-956	view file DOI
2020-07	Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors Keam, Bhumsuk; Kang, Chang Kyung; Jun, Kang Il; Moon, Song Mi; Suh, Koung Jin; Lee, Dae-Won; Ock, Chan-Young; Kim, Miso; Choi, Yunhee; Lim, Yoojoo; Lee, Kyung-Hun; Kim, Se Hyun; Kim, Tae Min; Kim, Tae-Yong; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Lee, Jong Seok; Kim, Eu Suk; Kim, Hong Bin; Kim, Nam-Joong; Kim, Yu Jung; Park, Wan Beom; Oh, Myoung-Don Clinical Infectious Diseases, Vol.71 No.2, pp.422-425	DOI
2020-10	Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer Lee, Kyung-Hun; Chie, Eui Kyu; Im, Seock-Ah; Kim, Jee Hyun; Kwon, Jihyun; Han, Sae-Won; Oh, Do-Youn; Jang, Jin-Young; Kim, Jae-Sung; Kim, Tae-You; Bang, Yung-Jue; Kim, Sun Whe; Ha, Sung W. Cancer Research and Treatment, Vol.53 No.4, pp.1096-1103	DOI
2020-10	Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer Kim, Jin Won; Cho, Sung-Yup; Chae, Jeesoo; Kim, Ji-Won; Kim, Tae-Yong; Lee, Keun-Wook; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.52 No.4, pp.1178-1187	DOI
2021-05	A target-mediated drug disposition population pharmacokinetic model of GC1118, a novel anti-EGFR antibody, in patients with solid tumors Chung, Tae Kyu; Lee, Hyun A.; Park, Sang-In; Oh, Do-Youn; Lee, Keun-Wook; Kim, Jin Won; Kim, Jee Hyun; Woo, Ahmi; Lee, Su Jin; Bang, Yung-Jue; Lee, Howard Clinical and Translational Science, Vol.14 No.3, pp.990-1001	DOI
2021-10	Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer Lee, Kyung-Hun; Chie, Eui Kyu; Im, Seock-Ah; Kim, Jee Hyun; Kwon, Jihyun; Han, Sae-Won; Oh, Do-Youn; Jang, Jin-Young; Kim, Jae-Sung; Kim, Tae-You; Bang, Yung-Jue; Kim, Sun Whe; Ha, Sung W. Cancer Research and Treatment, Vol.53 No.4, pp.1096-1103	DOI
2022-06	Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma Waguespack, Steven G.; Drilon, Alexander; Lin, Jessica J.; Brose, Marcia S.; McDermott, Ray; Almubarak, Mohammed; Bauman, Jessica; Casanova, Michela; Krishnamurthy, Anuradha; Kummar, Shivaani; Leyvraz, Serge; Oh, Do-Youn; Park, Keunchil; Sohal, Davendra; Sherman, Eric; Norenberg, Ricarda; Silvertown, Josh D.; Brega, Nicoletta; Hong, David S.; Cabanillas, Maria E. European Journal of Endocrinology, Vol.187 No.1, pp.631-643	DOI
2022-06	Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study Oh, Do-Youn; Lee, Kyung-Hun; Lee, Dae-Won; Yoon, Jeesun; Kim, Tae-Yong; Bang, Ju-Hee; Nam, Ah-Rong; Oh, Kyoung-Seok; Kim, Jae-Min; Lee, Young; Guthrie, Violeta; McCoon, Patricia; Li, Weimin; Wu, Song; Zhang, Qu; Rebelatto, Marlon C; Kim, Jin Won The Lancet Gastroenterology & Hepatology, Vol.7 No.6, pp.522-532	DOI
2022-07	Health-related quality of life in patients treated with pembrolizumab for microsatellite instability–high/mismatch repair–deficient advanced solid tumours: Results from the KEYNOTE-158 study Maio, Michele; Amonkar, Mayur M.; Norquist, Josephine M.; Ascierto, Paolo A.; Manzyuk, Ludmila; Motola-Kuba, Daniel; Penel, Nicolas; Cassier, Philippe A.; Bariani, Giovanni M.; De Jesus Acosta, Ana; Doi, Toshihiko; Longo, Federico; Miller, Wilson H.; Oh, Do-Youn; Gottfried, Maya; Wang, Ruixue; Norwood, Kevin; Marabelle, Aurelien European Journal of Cancer, Vol.169, pp.188-197	DOI
2022-07	Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head-and-neck cancer Doki, Yuichiro; Ueno, Makoto; Hsu, Chih-Hung; Oh, Do-Youn; Park, Keunchil; Yamamoto, Noboru; Ioka, Tatsuya; Hara, Hiroki; Hayama, Manabu; Nii, Masahiro; Komuro, Keiko; Sugimoto, Mariko; Tahara, Makoto Cancer Medicine, Vol.11 No.13, pp.2550-2560	DOI

1 2 3 4 5